93 results on '"Malyugin B."'
Search Results
2. Comparative Analysis of Clinical and Functional Results of Standard and Modified Endothelial and Descemet Membrane Transplantation Techniques
- Author
-
Malyugin, B. E., primary, Gelyastanov, A. M., additional, Antonova, O. P., additional, Belodedova, A. V., additional, and Khaletskaya, A. A., additional
- Published
- 2023
- Full Text
- View/download PDF
3. Correction to: Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment (Advances in Therapy, (2022), 39, 8, (3501-3521), 10.1007/s12325-022-02166-6)
- Author
-
Oddone, F., Kirwan, J., Lopez-Lopez, F., Zimina, M., Fassari, C., Hollo, G., Faschinger, C., Chen, E., Nemeth, G., Bator, G., Tsorbatzoglou, A., Acs, T., Ferencz, M., Sohajda, Z., Toth, J., Volner, V., Vogt, G., Biro, Z., Facsko, A., Nemes, J., Berta, A., Elek, I., Ng, E., Rossi, G., Rossetti, L., Vetrugno, M., Iester, M., Marchini, G., Scorcia, V., Staurenghi, G., Cagini, C., Salgarello, T., Bettin, P., Figus, M., Scuderi, G. L., De Cilla, S., Grundmane, I., Linavska, N., Volksone, L., Laganovska, G., Baumane, K., Lemij, H., Gundersen, K. G., Erichev, V., Adbulaeva, E., Karlova, E., Zakharova, E., Panova, I., Malyugin, B., Rodriguez-Agirretxe, I., Valladares, A. M., del Castillo, J. B., Gimenez, R., Vallejo, M. P., Garcia-Medina, J. J., Lopez, A. A., Torregrosa, S., Loscos, J., Kolko, M., Ansari, E., Broadway, D., Claridge, K., Ruben, S., Nita, A., Smith, M., Moosavi, A., King, A. J. W., and Kinsella, M.
- Subjects
Pharmacology (medical) ,General Medicine - Abstract
The authors would like to acknowledge missing data for all prior latanoprost users as a whole. The following sentence has been added to the manuscript (page 8, first paragraph): Mean (SD) reduction from baseline at Month 6 for users of all latanoprost formulations (preserved and PF) was 6.1 (4.25) mmHg (25.9%; p\0.0001). The authors have also prepared a table to summarise the change in intraocular pressure following a switch to the preservative-free tafluprost/timolol fixed-dose combination from all latanoprost formulations (preserved and preservative-free formulations). See Table 1 below.(Table Preseneted.) .The original article has been corrected.
- Published
- 2022
- Full Text
- View/download PDF
4. Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment
- Author
-
Oddone, F., Kirwan, J., Lopez-Lopez, F., Zimina, M., Fassari, C., Hollo, G., Faschinger, C., Chen, E., Nemeth, G., Bator, G., Tsorbatzoglou, A., Acs, T., Ferencz, M., Sohajda, Z., Toth, J., Volner, V., Vogt, G., Biro, Z., Facsko, A., Nemes, J., Berta, A., Elek, I., Ng, E., Rossi, G., Rossetti, L., Vetrugno, M., Iester, M., Marchini, G., Scorcia, V., Staurenghi, G., Cagini, C., Salgarello, T., Bettin, P., Figus, M., Scuderi, G. L., De Cilla, S., Grundmane, I., Linavska, N., Volksone, L., Laganovska, G., Baumane, K., Lemij, H., Gundersen, K. G., Erichev, V., Adbulaeva, E., Karlova, E., Zakharova, E., Panova, I., Malyugin, B., Rodriguez-Agirretxe, I., Valladares, A. M., del Castillo, J. B., Gimenez, R., Vallejo, M. P., Garcia-Medina, J. J., Lopez, A. A., Torregrosa, S., Loscos, J., Kolko, M., Ansari, E., Broadway, D., Claridge, K., Ruben, S., Nita, A., Smith, M., Moosavi, A., King, A. J. W., and Kinsella, M.
- Subjects
Adult ,Hyperemia ,Tafluprost/timolol fixed-dose combination ,Ocular hypertension ,VISIONARY study ,Travoprost ,Preservative-free topical medication ,Prostaglandin analogue monotherapy ,Humans ,Pharmacology (medical) ,Prospective Studies ,Chronic ,Open-angle glaucoma ,Antihypertensive Agents ,Intraocular Pressure ,Real-world evidence ,Prostaglandins A ,Fatigue Syndrome, Chronic ,Prostaglandins F ,Glaucoma ,General Medicine ,Beta-blocker monotherapy ,Fatigue Syndrome ,Drug Combinations ,Bimatoprost ,Open-Angle ,Timolol ,Latanoprost ,Glaucoma, Open-Angle - Abstract
Introduction: The VISIONARY study demonstrated statistically significant intraocular pressure (IOP) reductions with the preservative-free fixed-dose combination of tafluprost 0.0015% and timolol 0.5% (PF tafluprost/timolol FC) in open-angle glaucoma (OAG) or ocular hypertension (OHT) patients, sub-optimally controlled with topical prostaglandin analogue (PGA) or beta-blocker monotherapy. Current subanalyses have examined these data according to the baseline monotherapy. Methods: A European, prospective, observational study included adults (aged ≥ 18 years) with OAG or OHT, who were switched to the PF tafluprost/timolol FC from PGA or beta-blocker monotherapy. Treatment outcomes were reported according to prior monotherapy subgroup: beta-blocker, preserved latanoprost, PF-latanoprost, bimatoprost, tafluprost, and travoprost. Endpoints included the mean change from baseline regarding IOP, conjunctival hyperemia, and corneal fluorescein staining (CFS) at Week 4 and Week 12, and at Month 6. Results: The subanalysis included 577 patients. All prior monotherapy subgroups demonstrated statistically significant IOP reductions from baseline at Week 4, that were maintained through Month 6 (p
- Published
- 2022
- Full Text
- View/download PDF
5. Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
- Author
-
Oddone, F., Tanga, L., Kothy, P., Hollo, G., Faschinger, C., Chen, E., Nemeth, G., Bator, G., Tsorbatzoglou, A., Acs, T., Ferencz, M., Sohajda, Z., Toth, J., Volner, V., Vogt, G., Biro, Z., Facsko, A., Nemes, J., Berta, A., Elek, I., Ng, E., Rossi, G., Rossetti, L., Vetrugno, M., Iester, M., Marchini, G., Scorcia, V., Staurenghi, G., Cagini, C., Salgarello, T., Bettin, P., Figus, M., Scuderi, G. L., De Cilla, S., Grundmane, I., Linavska, N., Volksone, L., Laganovska, G., Baumane, K., Lemij, H., Gundersen, K. G., Zimina, M., Erichev, V., Karlova, E., Zakharova, E., Panova, I., Malyugin, B., Aguirrec, I. R., Lopez-Lopez, F., Valladares, A. M., del Castillo, J. B., Gimenez, R., Vallejo, M. P., Medina, J. G., Lopez, A. A., Torregrosa, S., Loscos, J., Kolko, M., Ansari, E., Broadway, D., Claridge, K., Ruben, S., Kirwan, J., Nita, A., Smith, M., Moosavi, A., King, A. J. W., and Kinsella, M.
- Subjects
Male ,030213 general clinical medicine ,Intraocular pressure ,genetic structures ,Ocular hypertension ,Timolol ,Glaucoma ,0302 clinical medicine ,Prostaglandins, Synthetic ,Medicine ,Pharmacology (medical) ,Prospective Studies ,Open-angle glaucoma ,media_common ,Original Research ,Aged, 80 and over ,Fixed-dose combination ,General Medicine ,Middle Aged ,Drug Combinations ,Tolerability ,030220 oncology & carcinogenesis ,Female ,Glaucoma, Open-Angle ,medicine.drug ,medicine.medical_specialty ,medicine.drug_class ,Tonometry, Ocular ,03 medical and health sciences ,Preservative-free topical medication ,Ophthalmology ,Humans ,media_common.cataloged_instance ,European union ,Antihypertensive Agents ,Intraocular Pressure ,Aged ,business.industry ,Preservatives, Pharmaceutical ,Prostaglandins F ,Tafluprost ,Correction ,medicine.disease ,eye diseases ,sense organs ,Prostaglandin analogue ,business - Abstract
Introduction: A non-interventional, multicenter, European, prospective evaluation of the effectiveness, tolerability, and safety of a topical preservative-free tafluprost (0.0015%) and timolol (0.5%) fixed-dose combination (PF tafluprost/timolol FC) in adults with open-angle glaucoma (OAG) and ocular hypertension (OHT) demonstrating insufficient response to topical beta-receptor blockers or prostaglandin analogue (PGA) monotherapy. Methods: Mean intraocular pressure (IOP) change from baseline was measured at study visits following a switch to PF tafluprost/timolol FC. Primary endpoint was absolute mean IOP change at month 6. Change from baseline concerning ocular signs and symptoms was also explored. Results: Analyses included 577 patients (59.6% female). Mean age (SD) was 67.8 (11.67) years. Mean (SD) IOP reduction from baseline was significant at all study visits; 5.4 (3.76) mmHg (23.7%) at week 4, 5.9 (3.90) mmHg (25.6%) at week 12, and 5.7 (4.11) mmHg (24.9%) at month 6 (p < 0.0001 for all visits). At month 6, 69.2%, 53.6%, 40.0%, and 25.8% were responders based on ≥ 20%, ≥ 25%, ≥ 30%, and ≥ 35% cutoff values for mean IOP, respectively. Significant reductions were observed concerning corneal fluorescein staining (p < 0.0001), dry eye symptoms, irritation, itching, and foreign body sensation (p < 0.001 for each parameter). Conjunctival hyperemia was significantly reduced at all study visits (p < 0.0001 at each visit). Overall, 69 treatment-related adverse events (AEs) were reported, one of which was serious (status asthmaticus). Most AEs were mild to moderate in severity, and the majority had resolved or were resolving at the end of the study period. Conclusion: In clinical practice, PF tafluprost/timolol FC provided statistically and clinically significant IOP reductions in patients with OAG and OHT insufficiently controlled on or intolerant to PGA or beta-receptor blocker monotherapy. The full IOP reduction appeared at week 4 and was maintained over the 6-month study period. Key symptoms of ocular surface health improved. Trial Registration: European Union electronic Register of Post-Authorisation Studies (EU PAS) register number, EUPAS22204.
- Published
- 2020
- Full Text
- View/download PDF
6. Correction: One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy (Eye, (2020), 10.1038/s41433-020-0869-1)
- Author
-
Bandello, F., Coassin, M., Di Zazzo, A., Rizzo, S., Biagini, I., Pozdeyeva, N., Sinitsyn, M., Verzin, A., De Rosa, P., Calabro, F., Avitabile, T., Bonfiglio, V., Fasce, F., Barraquer, R., Mateu, J. L., Kohnen, T., Carnovali, M., Malyugin, B., Aragona, P., Arvedi, P., Cagini, C., Caretti, L., Cavallini, G. M., Cillino, S., Figini, I., Franco, L. M., La Mantia, A., Laborante, A., Lanzetta, P., Marcigaglia, M., Mariotti, C., Martini, E., Mastropasqua, L., Morselli, S., Passani, F., Pece, A., Pertile, G., Pioppo, A., Pirondini, C., Prantera, M., Rapisarda, A., Romano, M. R., Scarpa, G., Schiano-Lomoriello, D., Scorcia, V., Scuderi, G., Semeraro, F., Spedale, F., Staurenghi, G., Tognetto, D., Tosi, M., Trabucchi, G., Trivella, F., Villani, E., Vento, A., Vinciguerra, P., Alio, J. L., Alfonso Sanchez, J. F., Montiel, F. A., Lorenz, K., Panova, I., Eremina, A., Ciprandi, G., Bandello, F., Coassin, M., Di Zazzo, A., Rizzo, S., Biagini, I., Pozdeyeva, N., Sinitsyn, M., Verzin, A., De Rosa, P., Calabro, F., Avitabile, T., Bonfiglio, V., Fasce, F., Barraquer, R., Mateu, J. L., Kohnen, T., Carnovali, M., Malyugin, B., Aragona, P., Arvedi, P., Cagini, C., Caretti, L., Cavallini, G. M., Cillino, S., Figini, I., Franco, L. M., La Mantia, A., Laborante, A., Lanzetta, P., Marcigaglia, M., Mariotti, C., Martini, E., Mastropasqua, L., Morselli, S., Passani, F., Pece, A., Pertile, G., Pioppo, A., Pirondini, C., Prantera, M., Rapisarda, A., Romano, M. R., Scarpa, G., Schiano-Lomoriello, D., Scorcia, V., Scuderi, G., Semeraro, F., Spedale, F., Staurenghi, G., Tognetto, D., Tosi, M., Trabucchi, G., Trivella, F., Villani, E., Vento, A., Vinciguerra, P., Alio, J. L., Alfonso Sanchez, J. F., Montiel, F. A., Lorenz, K., Panova, I., Eremina, A., and Ciprandi, G.
- Subjects
not available ,Drug Therapy - Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- Published
- 2020
7. Conformation and kinetic characteristics of interactions between local anesthetics and aqueous solutions of hydroxypropylmethylcellulose
- Author
-
Galenko-Yaroshevskii, A. P., Varlashkina, I. A., Takhchidi, Kh. P., Malyugin, B. E., and Dukhanin, A. S.
- Published
- 2007
- Full Text
- View/download PDF
8. Cultivated autologous oral mucosal epithelial transplantation
- Author
-
Borzenok, S. A., primary, Malyugin, B. E., additional, Gerasimov, M. Yu., additional, and Ostrovsky, D. S., additional
- Published
- 2021
- Full Text
- View/download PDF
9. The New Concept of IOL Multifocality: Gradient Refractive Index Optics
- Author
-
Takhchidi, K, primary, Malyugin, B, additional, Morozova, T, additional, and Kravchuk, O, additional
- Published
- 2008
- Full Text
- View/download PDF
10. Experimental Rationale for Using an Eximer Laser for Preparation of Ultrathin Graft for Posterior Lamellar Keratoplasty
- Author
-
Pashtaev, A. N., primary, Pashtaev, N. P., additional, Pozdeyeva, N. A., additional, Mukhina, I. V., additional, Izmailova, S. B., additional, Korotchenko, S. A., additional, Katmakov, K. I., additional, Alieva, S. S., additional, Kuzmichev, K. N., additional, and Malyugin, B. E., additional
- Published
- 2020
- Full Text
- View/download PDF
11. Inverted Posterior Femto-Keratoplasty: Quality of the Surface of the Corneal Section and Preliminary Clinical Outcomes
- Author
-
Pashtaev, A. N., primary, Malyugin, B. E., additional, Izmailova, S. B., additional, Pashtaev, N. P., additional, Kuzmichev, K. N., additional, Alieva, S. S., additional, and Katmakov, K. I., additional
- Published
- 2020
- Full Text
- View/download PDF
12. Molecular mechanisms of vasoconstrictor action of imidazo[1,2-α]benzimidazole derivative RU-117 possessing local anesthetic properties
- Author
-
Galenko-Yaroshevskii, A. P., Dukhanin, A. S., Takhchidi, Kh. P., and Malyugin, B. E.
- Published
- 2007
- Full Text
- View/download PDF
13. Correction to: Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study (Advances in Therapy, (2020), 37, 4, (1436-1451), 10.1007/s12325-020-01239-8)
- Author
-
Oddone, F., Tanga, L., Kothy, P., Hollo, G., Faschinger, C., Chen, E., Nemeth, G., Bator, G., Tsorbatzoglou, A., Acs, T., Ferencz, M., Sohajda, Z., Toth, J., Volner, V., Vogt, G., Biro, Z., Facsko, A., Nemes, J., Berta, A., Elek, I., Ng, E., Rossi, G., Rossetti, L., Vetrugno, M., Iester, M., Marchini, G., Scorcia, V., Staurenghi, G., Cagini, C., Salgarello, T., Bettin, P., Figus, M., Scuderi, G. L., De Cilla, S., Grundmane, I., Linavska, N., Volksone, L., Laganovska, G., Baumane, K., Lemij, H., Gundersen, K. G., Zimina, M., Erichev, V., Karlova, E., Zakharova, E., Panova, I., Malyugin, B., Aguirrec, I. R., Lopez-Lopez, F., Valladares, A. M., del Castillo, J. B., Gimenez, R., Vallejo, M. P., Garcia-Medina, J. J., Lopez, A. A., Torregrosa, S., Loscos, J., Kolko, M., Ansari, E., Broadway, D., Claridge, K., Ruben, S., Kirwan, J., Nita, A., Smith, M., Moosavi, A., King, A. J. W., and Kinsella, M.
- Published
- 2020
14. Correction: One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy (Eye, (2020), 34, 11, (2112-2122), 10.1038/s41433-020-0869-1)
- Author
-
Bandello, F., Coassin, M., Di Zazzo, A., Rizzo, S., Biagini, I., Pozdeyeva, N., Sinitsyn, M., Verzin, A., De Rosa, P., Calabro, F., Avitabile, T., Bonfiglio, V., Fasce, F., Barraquer, R., Mateu, J. L., Kohnen, T., Carnovali, M., Malyugin, B., Aragona, P., Arvedi, P., Cagini, C., Caretti, L., Cavallini, G. M., Cillino, S., Figini, I., Franco, L. M., La Mantia, A., Laborante, A., Lanzetta, P., Marcigaglia, M., Mariotti, C., Martini, E., Mastropasqua, L., Morselli, S., Passani, F., Pece, A., Pertile, G., Pioppo, A., Pirondini, C., Prantera, M., Rapisarda, A., Romano, M. R., Scarpa, G., Schiano-Lomoriello, D., Scorcia, V., Scuderi, G., Semeraro, F., Spedale, F., Staurenghi, G., Tognetto, D., Tosi, M., Trabucchi, G., Trivella, F., Villani, E., Vento, A., Vinciguerra, P., Alio, J. L., Alfonso Sanchez, J. F., Montiel, F. A., Lorenz, K., Panova, I., Eremina, A., and Ciprandi, G.
- Published
- 2020
15. Comparative analysis of the functional results after implantation of various diffractive trifocal intraocular lenses
- Author
-
Malyugin, B. E., primary, Sobolev, N. P., additional, Fomina, O. V., additional, and Belokopytov, A. V., additional
- Published
- 2020
- Full Text
- View/download PDF
16. Transplantation of endothelium and Descemet's membrane
- Author
-
Malyugin, B. E., primary, Shilova, N. F., additional, Anisimova, N. S., additional, and Antonova, O. P., additional
- Published
- 2019
- Full Text
- View/download PDF
17. Comparative Analysis of Refractive Result Predictability During Iridocapsular and Iridovitreal Fixation of Biplanar Intraocular Lens
- Author
-
Malyugin, B. E., primary, Panteleev, E. N., additional, Bessarabov, A. N., additional, Pokrovskiy, D. F., additional, Semakina, A. S., additional, and Abdullaeva, S. A., additional
- Published
- 2018
- Full Text
- View/download PDF
18. Mechanical dilation of the pupil and its possible applications in femtosecond laser-assisted cataract surgery
- Author
-
Malyugin, B. E., primary and Anisimova, N. S., additional
- Published
- 2018
- Full Text
- View/download PDF
19. Highly effective 525 nm femtosecond laser crosslinking of collagen and strengthening of a human donor cornea
- Author
-
Shavkuta, B S, primary, Gerasimov, M Y, additional, Minaev, N V, additional, Kuznetsova, D S, additional, Dudenkova, V V, additional, Mushkova, I A, additional, Malyugin, B E, additional, Kotova, S L, additional, Timashev, P S, additional, Kostenev, S V, additional, Chichkov, B N, additional, and Bagratashvili, V N, additional
- Published
- 2017
- Full Text
- View/download PDF
20. Investigation on the intracorneal lens material biocompatibility using the model of the corneal stromal cell culture
- Author
-
Malyugin, B. E., primary, Borzenok, S. A., additional, Mushkova, I. A., additional, Ostrovskiy, D. S., additional, Popov, I. A., additional, and Shkandina, Yu. V., additional
- Published
- 2017
- Full Text
- View/download PDF
21. Clinical and functional results of one-step phaco surgery and central descemetorhexis for cataract and Fuchs primary endothelial corneal dystrophy
- Author
-
Malyugin, B. E., primary, Izmaylova, S. B., additional, Malyutina, E. A., additional, Antonova, O. P., additional, and Gelyastanov, A. M., additional
- Published
- 2017
- Full Text
- View/download PDF
22. Regional ophthalmological cluster as a resource basis for the process and the procedure of specialist accreditation
- Author
-
Chukhraev, A. M., primary, Khodzhaev, N. S., additional, Malyugin, B. E., additional, Doga, A. V., additional, and Zabolotniy, A. G., additional
- Published
- 2017
- Full Text
- View/download PDF
23. Femtosecond laser-assisted anterior lamellar keratoplasty for keratoconus
- Author
-
PASHTAEV, A, primary and MALYUGIN, B, additional
- Published
- 2014
- Full Text
- View/download PDF
24. S.Fyodorov Eye Microsurgery Complex: Past, present and future
- Author
-
MALYUGIN, B, primary and CHUKRAYOV, A, additional
- Published
- 2014
- Full Text
- View/download PDF
25. Surgical options with narrow pupil and floppy iris syndrome
- Author
-
Malyugin, B, primary
- Published
- 2010
- Full Text
- View/download PDF
26. Review of surgical management of small pupils in cataract surgery: use of the Malyugin ring.
- Author
-
Malyugin B
- Published
- 2010
- Full Text
- View/download PDF
27. CELL TECHNOLOGIES, TISSUE ENGINEERING AND REGENERATIVE MEDICINE
- Author
-
Babenko, V. A., Silachev, D. N., Goryunov, K., Pevzner, I. B., Popkov, V. A., Zorova, L. D., Plotnikov, E. Y., Zorov, D. B., Sukhikh, G. T., Belodedova, A., Antonova, O. P., Malyugin, B. E., Bol Shov, A., Akhmad, Y. A., Tret Yak, S., Khryshchanovich, V. Y., Borzenok, S. A., Tonayeva, K. D., Ostrovskiy, D. S., Akhmedov, A. K., Kalinnikov, Y. Y., Gavrilova, N. A., Agapov, I. I., Revishchin, A., Tishchenko, O. E., Bobrova, M. M., Safonova, L. A., Agammedov, M. B., Pavlova, G., Gonikova, Z. Z., Nikol Skaya, A. O., Kirsanova, L. A., Shagidulin, M. Y., Onishchenko, N. A., Sevast Yanov, V., Granov, D. A., Sheraliyev, A. R., Polikarpov, A. A., Tileubergenov, I. I., Gerasimova, O. A., Moiseyenko, A., Polekhin, A. S., Raskin, G. A., Efimov, A. E., Agapova, O., Zhura, A., Kulikovskaya, V., Gilevskaya, K. S., Kraskovskiy, A. N., Agagbekov, V. E., Kerimov, T. Z., Zheltonozhko, A. A., Korotkov, S., Nosik, A., Primakova, E. A., Nazarova, E. A., Dedyulya, N., Buzuk, E. S., Petrovskaya, E. G., Yunova, Y. N., Dmitriyeva, M., Efimov, D. Y., Shturich, I. P., Pikirenya, I. I., Shcherba, A. E., Kalachik, O., Krivenko, S., Rummo, O. O., Kuznetsova, E. G., Kuryleva, O. M., Salomatina, L. A., Kulikov, A., Arkhipova, L., Gavrilyuk, V. B., Mndlyan, E. Y., Rudnev, V. R., Glazkova, P. A., Glazkov, A. A., Kulikov, D. A., Lokhonina, A., Nikitina, M. P., El Chaninov, A., Fatkhudinov, T. K., Gelyastanov, A. M., Nemets, E. A., Pankina, A. P., Symanovich, A. A., Savchenkova, I. P., Savchenkova, E. A., Salikhova, D., Georgiy Leonov, Namestnikova, D. D., Bulatenko, N., Gubskiy, I. L., Bukharova, T. B., Sukhinich, K. K., Mel Nikov, P. A., Cherkashova, E. A., Gubskiy, L., Yarygin, K. N., Gol Dshteyn, D., Fomichev, A., Chernyavskiy, A. M., Gulyayeva, K. K., Poveshchenko, O., Kareva, Y. E., Minin, S. M., Nikitin, N. A., Antonova, L., Senokosova, E. A., Sil Nikov, V. N., Krivkina, E. O., Kudryavtseva, Y. A., Barbarash, L. S., Basok, Y. B., Grigor Yev, A. M., Kirillova, A. D., Kovalev, A., Lebedeva, A., Muslimov, S. A., Shangina, O. R., Afanas Yev, S. A., Kondrat Yeva, D. S., Popov, S., Nigmatullin, R. T., Kutushev, R. Z., Motygullin, B. R., Mukhametova, D. A., Ponomareva, A. S., Miloserdov, I. A., Sergeyeva, N. S., Khesuani, Y. D., Kirsanova, V. A., Karalkin, P. A., Sviridova, I. K., Polyakov, P. A., Skaletskaya, G. N., Skaletskiy, N. N., and Bubentsova, G. N.
28. Anterior Ciliary Sclerotomy using Collagen T-shaped Implants for Treatment of Presbyopia
- Author
-
Malyugin B., Antonian S., Lohman B.D., Malyugin B., Antonian S., and Lohman B.D.
- Abstract
We assessed the long-term clinical outcomes and evaluate the safety, efficacy and stability of anterior ciliary sclerotomy with collagen T-shaped implants in 19 patients The study revealed that anterior ciliary sclerotomy with collagen T-shaped implants for the treatment of presbyopia is a safe procedure, but the effect is temporary and diminishes with time.
29. Surgeon: Malyugin ring helpful in small-pupil phacoemulsification.
- Author
-
Malyugin B
- Abstract
The ring's designer describes his surgical method for using the device in complicated phaco cases. [ABSTRACT FROM AUTHOR]
- Published
- 2008
30. One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy
- Author
-
Bandello, Francesco, Coassin, Marco, Di Zazzo, Antonio, Rizzo, Stanislao, Biagini, Ilaria, Pozdeyeva, Nadezhda, Sinitsyn, Maksim, Verzin, Alexander, De Rosa, Pasquale, Calabrò, Francesco, Avitabile, Teresio, Bonfiglio, Vincenza, Fasce, Francesco, Barraquer, Rafael, Mateu, Josè Lamarca, Kohnen, Thomas, Carnovali, Marino, Malyugin, Boris, Pasquale, Aragona, Paolo, Arvedi, Carlo, Cagini, Luigi, Caretti, Gian Maria Cavallini, Salvatore, Cillino, Innocente, Figini, Livio Marco Franco, Alberto La Mantia, Antonio, Laborante, Paolo, Lanzetta, Mattia, Marcigaglia, Cesare, Mariotti, Enrico, Martini, Leonardo, Mastropasqua, Simonetta, Morselli, Franco, Passani, Alfredo, Pece, Grazia, Pertile, Antonino, Pioppo, Cesare, Pirondini, Marcello, Prantera, Antonio, Rapisarda, Romano, Mario R., Giuseppe, Scarpa, Domenico, Schiano-Lomoriello, Vincenzo, Scorcia, Gianluca, Scuderi, Francesco, Semeraro, Franco, Spedale, Giovanni, Staurenghi, Tognetto, Daniele, Marco, Tosi, Giuseppe, Trabucchi, Fausto, Trivella, Edoardo, Villani, Andrea, Vento, Paolo, Vinciguerra, Alió, Jorge L., Alfonso Sanchez, Josè F., Francisco Arnalich Montiel, Katrin, Lorenz, Irina, Panova, Alena, Eremina, Giorgio, Ciprandi, Bandello F., Coassin M., Di Zazzo A., Rizzo S., Biagini I., Pozdeyeva N., Sinitsyn M., Verzin A., De Rosa P., Calabro F., Avitabile T., Bonfiglio V., Fasce F., Barraquer R., Mateu J.L., Kohnen T., Carnovali M., Malyugin B., Aragona P., Arvedi P., Cagini C., Caretti L., Cavallini G.M., Cillino S., Figini I., Franco L.M., La Mantia A., Laborante A., Lanzetta P., Marcigaglia M., Mariotti C., Martini E., Mastropasqua L., Morselli S., Passani F., Pece A., Pertile G., Pioppo A., Pirondini C., Prantera M., Rapisarda A., Romano M.R., Scarpa G., Schiano-Lomoriello D., Scorcia V., Scuderi G., Semeraro F., Spedale F., Staurenghi G., Tognetto D., Tosi M., Trabucchi G., Trivella F., Villani E., Vento A., Vinciguerra P., Alio J.L., Alfonso Sanchez J.F., Montiel F.A., Lorenz K., Panova I., Eremina A., Ciprandi G., Francesco, Bandello, Marco, Coassin, Antonio, Di Zazzo, Stanislao, Rizzo, Ilaria, Biagini, Nadezhda, Pozdeyeva, Maksim, Sinitsyn, Alexander, Verzin, Pasquale, De Rosa, Francesco, Calabrò, Teresio, Avitabile, Vincenza, Bonfiglio, Francesco, Fasce, Rafael, Barraquer, Josè Lamarca, Mateu, Thomas, Kohnen, Marino, Carnovali, Boris, Malyugin, Aragona, Pasquale, Arvedi, Paolo, Cagini, Carlo, Caretti, Luigi, Maria Cavallini, Gian, Cillino, Salvatore, Figini, Innocente, Marco Franco, Livio, La Mantia, Alberto, Laborante, Antonio, Lanzetta, Paolo, Marcigaglia, Mattia, Mariotti, Cesare, Martini, Enrico, Mastropasqua, Leonardo, Morselli, Simonetta, Passani, Franco, Pece, Alfredo, Pertile, Grazia, Pioppo, Antonino, Pirondini, Cesare, Prantera, Marcello, Rapisarda, Antonio, Romano, Mario R., Scarpa, Giuseppe, Schiano-Lomoriello, Domenico, Scorcia, Vincenzo, Scuderi, Gianluca, Semeraro, Francesco, Spedale, Franco, Staurenghi, Giovanni, Tognetto, Daniele, Tosi, Marco, Trabucchi, Giuseppe, Trivella, Fausto, Villani, Edoardo, Vento, Andrea, Vinciguerra, Paolo, Alió, Jorge L., Alfonso Sanchez, Josè F., Arnalich Montiel, Francisco, Lorenz, Katrin, Panova, Irina, Eremina, Alena, Ciprandi, Giorgio, Bandello, F., Coassin, M., Di Zazzo, A., Rizzo, S., Biagini, I., Pozdeyeva, N., Sinitsyn, M., Verzin, A., De Rosa, P., Calabro, F., Avitabile, T., Bonfiglio, V., Fasce, F., Barraquer, R., Mateu, J. L., Kohnen, T., Carnovali, M., Malyugin, B., Aragona, P., Arvedi, P., Cagini, C., Caretti, L., Cavallini, G. M., Cillino, S., Figini, I., Franco, L. M., La Mantia, A., Laborante, A., Lanzetta, P., Marcigaglia, M., Mariotti, C., Martini, E., Mastropasqua, L., Morselli, S., Passani, F., Pece, A., Pertile, G., Pioppo, A., Pirondini, C., Prantera, M., Rapisarda, A., Romano, M. R., Scarpa, G., Schiano-Lomoriello, D., Scorcia, V., Scuderi, G., Semeraro, F., Spedale, F., Staurenghi, G., Tognetto, D., Tosi, M., Trabucchi, G., Trivella, F., Villani, E., Vento, A., Vinciguerra, P., Alio, J. L., Alfonso Sanchez, J. F., Montiel, F. A., Lorenz, K., Panova, I., Eremina, A., and Ciprandi, G.
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Levofloxacin ,Article ,Dexamethasone ,Cataract ,03 medical and health sciences ,0302 clinical medicine ,Endophthalmitis ,Pharmacotherapy ,Postoperative Complications ,Internal medicine ,medicine ,Tobramycin ,Clinical endpoint ,Humans ,Endophthalmitis, Cataract, Intracameral cefuroxime ,Adverse effect ,business.industry ,Cataract surgery ,Intracameral cefuroxime ,medicine.disease ,not applicable ,Anti-Bacterial Agents ,Ophthalmology ,Italy ,Spain ,030221 ophthalmology & optometry ,Ophthalmic Solutions ,business ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Background: Cataract surgery is the most common operation performed worldwide. A fixed topical corticosteroid-antibiotic combination is usually prescribed in clinical practice for 2 or more weeks to treat post surgical inflammation and prevent infection. However, this protracted schedule may increase the incidence of corticosteroid-related adverse events and notably promote antibiotic resistance. Methods: This International, multicentre, randomized, blinded-assessor, parallel-group clinical study evaluated the non-inferiority of 1-week levofloxacin/dexamethasone eye drops, followed by 1-week dexamethasone alone, vs. 2-week gold-standard tobramycin/dexamethasone (one drop QID for all schedules) to prevent and treat ocular inflammation and prevent infection after uncomplicated cataract surgery. Non-inferiority was defined as the lower limit of the 95% confidence interval (CI) around a treatment difference >–10%. The study randomized 808 patients enrolled in 53 centres (Italy, Germany, Spain and Russia). The primary endpoint was the proportion of patients without anterior chamber inflammation on day 15 defined as the end of treatment. Endophthalmitis was the key secondary endpoint. This study is registered with EudraCT code: 2018-000286-36. Results: After the end of treatment, 95.2% of the patients in the test arm vs. 94.9% of the control arm had no signs of inflammation in the anterior chamber (difference between proportions of patients = 0.028; 95% CI: −0.0275/0.0331). No case of endophthalmitis was reported. No statistically significant difference was evident in any of the other secondary endpoints. Both treatments were well tolerated. Conclusions: Non-inferiority of the new short pharmacological strategy was proven. One week of levofloxacin/dexamethasone prevents infection, ensures complete control of inflammation in almost all patients and may contain antibiotic resistance.
- Published
- 2020
31. COVID-19 outbreak and increased risk of amblyopia and epidemic myopia: Insights from EUROCOVCAT group
- Author
-
Miguel A. Teus, Daniele Tognetto, Boris Malyugin, Antoine P. Brézin, Arthur B. Cummings, Sandrine Zweifel, Mario Damiano Toro, Isabel Prieto, Omid Kermani, Dominique Bremond-Gignac, Ozlem Evren Kemer, Robert Rejdak, Toro, M. D., Bremond-Gignac, D., Brezin, A. P., Cummings, A. B., Kemer, O. E., Kermani, O., Malyugin, B. E., Prieto, I., Teus, M. A., Tognetto, D., Zweifel, S., Rejdak, R., Toro, Mario Damiano, Bremond-Gignac, Dominique, Brézin, Antoine Pierre, Cummings, Arthur Bernard, Kemer, Ozlem Evren, Kermani, Omid, Malyugin, Boris Edvard, Prieto, Isabel, Teus, Miguel Angel, Tognetto, Daniele, Zweifel, Sandrine, Rejdak, Robert, and University of Zurich
- Subjects
10018 Ophthalmology Clinic ,Adult ,genetic structures ,Coronavirus disease 2019 (COVID-19) ,Visual impairment ,visual impairment ,COVID-19 pandemic ,610 Medicine & health ,pediatric-eye care ,Amblyopia ,World health ,Disease Outbreaks ,irreversible blindness ,Pandemic ,Myopia ,Medicine ,Humans ,Child ,Pandemics ,amblyopia ,Disease Outbreak ,business.industry ,SARS-CoV-2 ,Outbreak ,COVID-19 ,General Medicine ,irreversible blindne ,2731 Ophthalmology ,eye diseases ,ophthalmology ,Increased risk ,Common cause and special cause ,Communicable Disease Control ,Optometry ,Abnormality ,medicine.symptom ,business ,Human - Abstract
The most common cause of vision impairment in children is amblyopia. It is defined as impaired visual acuity in one or both eyes that is present with no demonstrable abnormality of the visual pathway and is not immediately resolved by wearing glasses. After the World Health Organization (WHO) recognized COVID-19 as a global pandemic on March 11, 2020, widespread changes and restrictions to social and sanitary practices have presented significant issues in access to eye care during the COVID-19 pandemic. A reduction of more than 80% in pediatric eye care volume up to its total cessation has been observed in different departments. In this scenario, reduced or absent eyesight, due to delay in timely treatment of amblyopic conditions, could create major, long-lasting effects on all aspects of life, including daily personal activities, interacting with the community, school and work opportunities and the ability to access public services. Processes coming out of lockdown should be gradually easing restrictions giving priority to ophthalmology and eye care facilities so that amblyopia does not remain unattended and irreversible as in adults due to lack of timely treatments. If not reversible, this process could lead to a dramatic increase in disability and unsustainable social costs for many governments.
- Published
- 2022
32. Impact on Visual Acuity in Neovascular Age Related Macular Degeneration (nAMD) in Europe Due to COVID-19 Pandemic Lockdown
- Author
-
Danielle Tognetto, Mario Damiano Toro, Boris Malyugin, Rosa Giglio, Sandrine Zweifel, Mehmet Onen, Miguel A. Teus, Carolina Arruabarrena, Robert Rejdak, Arruabarrena, Carolina, Toro, Mario Damiano, Onen, Mehmet, Malyugin, Boris E, Rejdak, Robert, Tognetto, Danielle, Zweifel, Sandrine, Giglio, Rosa, Teus, Miguel A, Arruabarrena, C., Toro, M. D., Onen, M., Malyugin, B. E., Rejdak, R., Tognetto, D., Zweifel, S., Giglio, R., Teus, M. A., and University of Zurich
- Subjects
10018 Ophthalmology Clinic ,2019-20 coronavirus outbreak ,medicine.medical_specialty ,Visual acuity ,genetic structures ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,AMD ,COVID-19 ,SARS-CoV-2 ,neovascular age related macular degeneration ,610 Medicine & health ,2700 General Medicine ,Article ,03 medical and health sciences ,0302 clinical medicine ,Ophthalmology ,Age related ,Medicine ,In patient ,business.industry ,General Medicine ,Macular degeneration ,medicine.disease ,eye diseases ,Multicenter study ,030221 ophthalmology & optometry ,medicine.symptom ,business ,030217 neurology & neurosurgery - Abstract
This is a retrospective, multicenter study of consecutive patients with nAMD scheduled for a visit and/or a treatment with an intravitreal injection (IVI) during the 3 months before lockdown in the Ophthalmology Departments of six centers of Europe.The study was conducted on 546 patients, of which 55.13% were females, almost 100% of the patients were White/Caucasian race, and 71.53% of the patients presented a type 1 macular neovascularization (NVM). A total of 62.82% of patients (343 patients) that were on scheduled clinic visits and/or intravitreal injection treatment during the 3 months before the quarantine did not attend either to visit or for treatment during the lockdown. The mean number of injections during the lockdown was significantly reduced. This was followed by a significant reduction in the mean best-corrected visual acuity (BCVA) between the 3 months before the lockdown (mean BCVA of 60.68 ± 19.77 letters) and 6 months after lockdown (mean BCVA of 56.98 ± 22.59 letters). Patients with better BCVA before the lockdown and the ones showing neovascular activity were more likely to attend their scheduled visits and/or IVI treatments. The COVID-19 pandemic and the lockdown have led to a decrease in the number of IVI treatments in patients with nAMD, evidencing a significant vision loss at 6 months.
- Published
- 2021
33. Early impact of COVID-19 outbreak on eye care: Insights from EUROCOVCAT group
- Author
-
Tomasz Chorągiewicz, Chiara Posarelli, Miguel A. Teus, Riikka Törnblom, Ozlem Evren Kemer, Boris Malyugin, Michael A. Burdon, Robert Rejdak, Daniele Tognetto, Antoine P. Brézin, Arthur B. Cummings, Mario Damiano Toro, Isabel Prieto, Toro, M. D., Brezin, A. P., Burdon, M., Cummings, A. B., Evren Kemer, O., Malyugin, B. E., Prieto, I., Teus, M. A., Tognetto, D., Tornblom, R., Posarelli, C., Choragiewicz, T., and Rejdak, R.
- Subjects
medicine.medical_specialty ,Infectious Disease Transmission, Patient-to-Professional ,Eye Diseases ,Infectious Disease Transmission ,COVID-19 pandemic ,cornea transplantation ,Global Health ,Disease Outbreaks ,irreversible blindness ,Patient-to-Professional ,Hospital ,Pandemic ,Health care ,medicine ,Global health ,Humans ,Intensive care medicine ,Human resources ,retinal detachment surgery ,Emergency Service ,Disease Outbreak ,cataract surgery ,glaucoma ,intravitreal injection ,ophthalmology ,COVID-19 ,Delivery of Health Care ,Emergency Service, Hospital ,SARS-CoV-2 ,business.industry ,Transmission (medicine) ,Public health ,Outbreak ,Eye Disease ,General Medicine ,irreversible blindne ,business ,Elective Surgical Procedure ,Human - Abstract
The recent outbreak of coronavirus disease 2019 (COVID-19) has been declared a public health emergency worldwide. The scientific community has put in much effort and published studies that described COVID-19’s biology, transmission, clinical diagnosis, candidate therapeutics, and vaccines. However, to date, only a few data are available on the impact of COVID-19 pandemic on ophthalmological care in different health care systems, its future consequences in terms of disability, and access to sight-saving cures for many patients. To reduce human-to-human transmission of the virus and also ensure supply of infrastructures, human resources, and disposable medical devices to many regions, it is crucial to assess risks and postpone non-essential outpatient visits and elective surgical procedures, especially in older patients and those with comorbidities. This delay or suspension in essential eye procedures may cause significant and rapid vision impairment to irreversible blindness. Determining the risk-benefit profile of treating these ocular pathologies is a public health issue of supreme priority, even though many patients benefiting from therapeutic treatments are elderly, who are more vulnerable to COVID-19. If not reversible, this process could lead to a dramatic increase in disability and unsustainable social costs for many Governments.
- Published
- 2021
34. Rethinking Elective Cataract Surgery Diagnostics, Assessments, and Tools after the COVID-19 Pandemic Experience and Beyond: Insights from the EUROCOVCAT Group
- Author
-
Arthur B. Cummings, Antoine P. Brézin, Miguel A. Teus, Rosa Giglio, Mario Damiano Toro, Daniele Tognetto, Boris Malyugin, Isabel Prieto, Alex Lucia Vinciguerra, Robert Rejdak, Chiara De Giacinto, Ozlem Evren Kemer, Riikka Törnblom, Tognetto, Daniele, Brézin, Antoine P, Cummings, Arthur B, Malyugin, Boris E, Evren Kemer, Ozlem, Prieto, Isabel, Rejdak, Robert, Teus, Miguel A, Törnblom, Riikka, Toro, Mario D, Vinciguerra, Alex L, Giglio, Rosa, De Giacinto, Chiara, Tognetto, D., Brezin, A. P., Cummings, A. B., Malyugin, B. E., Kemer, O. E., Prieto, I., Rejdak, R., Teus, M. A., Tornblom, R., Toro, M. D., Vinciguerra, A. L., Giglio, R., and de Giacinto, C.
- Subjects
Telemedicine ,COVID-19 outbreak ,genetic structures ,medicine.medical_treatment ,Clinical Biochemistry ,Disease ,Review ,03 medical and health sciences ,0302 clinical medicine ,Quality of life (healthcare) ,Pandemic ,Health care ,medicine ,030212 general & internal medicine ,lcsh:R5-920 ,business.industry ,Phacoemulsification ,Perioperative ,cataract surgery ,Cataract surgery ,medicine.disease ,eye diseases ,phacoemulsification ,030221 ophthalmology & optometry ,Medical emergency ,business ,lcsh:Medicine (General) - Abstract
The progressive deterioration of the visual function in patients on waiting lists for cataract surgery has a negative impact on their quality of life, especially in the elderly population. Patient waiting times for cataract surgeries in many healthcare settings have increased recently due to the prolonged stop or slowdown of elective cataract surgery as a result of coronavirus disease 19 (COVID-19). The aim of this review is to highlight the impact of such a “de-prioritization” of cataract surgery and to summarize some critical issues and useful hints on how to reorganize cataract pathways, with a special focus on perioperative diagnostic tools during the recovery phase and beyond. The experiences of a group of surgeons originating from nine different countries, named the European COVID-19 Cataract Group (EUROCOVCAT), have been combined with the literature and recommendations from scientific ophthalmic societies and healthcare institutions. Key considerations for elective cataract surgery should include the reduction of the number of unnecessary visits and examinations, adoption of precautionary measures, and implementation of telemedicine instruments. New strategies should be adopted to provide an adequate level of assistance and to guarantee safety conditions. Flexibility will be the watchword and regular updates would be necessary following scientific insights and the development of the pandemic.
- Published
- 2020
35. Femtosecond Laser-Assisted Autologous Glueless Simple Limbal Epithelial Transplantation in Unilateral Limbal Stem Cell Deficiency: 12-Month Outcome of the First Clinical Cases.
- Author
-
Malyugin B, Svetlana K, Fabian M, Werner B, Boris K, and Maksim G
- Abstract
Purpose: Surgical treatment of unilateral limbal stem cell deficiency (LSCD) is based on limbal stem cell transplantation. Glueless simple limbal epithelial transplantation (G-SLET) technique implements several limbal micrografts harvested from the healthy eye of the same patient into the peripheral corneal tunnels without the use of fibrin glue and human amniotic membrane., Methods: A novel customized algorithm and software for a low-energy femtosecond laser (FSL) were developed and tested using 5 pairs of isolated porcine eyes. FSL-assisted G-SLET modification was assessed in 3 clinical cases of unilateral LSCD caused by chemical burns. Corneal epithelization efficacy, best-corrected visual acuity, corneal epithelial mapping, central corneal thickness, and impression cytology with immunohistochemical examination were evaluated. All patients were followed up for 12 months postoperatively., Results: The FSL set for 100% energy and the pattern of 8 nonpenetrating vertical cuts with oblique tunnel portions having variable incision depths and diameter of 8.5 mm and higher were selected for further clinical evaluation. Clinically, stable corneal epithelialization was achieved 2 to 3 weeks after intervention. At the 6-month follow-up, all patients had a healthy corneal epithelium with limbal micrografts visible inside the corneal tunnels. Best-corrected visual acuity markedly improved in 2 cases, but not in the third case with severe corneal stromal scarring. In addition, all patients noted a full-scale reduction in subjective complaints and substantial improvement in their quality of life., Conclusions: The FSL-assisted G-SLET is a new technique for autologous limbal stem cell transplantation in patients with unilateral LSCD. It allows the standardization of corneal tunnel localization and dimensions, thereby increasing the safety of the surgical procedure., Competing Interests: M. Fabian and B. Werner are employees of the Ziemer Ophthalmic Systems manufacturer of the femtosecond laser used in this study. The authors declare that they have no conflicts of interest., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
36. Novel and Previously Known Mutations of the KCNV2 Gene Cause Various Variants of the Clinical Course of Cone Dystrophy with Supernormal Rod Response in Children.
- Author
-
Alsalloum A, Mosin I, Shefer K, Mingaleva N, Kim A, Feoktistova S, Malyugin B, Boiko E, Sultanov S, Mityaeva O, and Volchkov P
- Abstract
Background/Objectives : Cone dystrophy with supernormal rod response (CDSRR) is a rare autosomal recessive retinal disorder characterized by a delayed and markedly decreased photoreceptor response. In this article, we aim to describe the clinical course and associated molecular findings in children with cone dystrophy with supernormal rod response associated with recessive mutations in the KCNV2 gene, which encodes a subunit (Kv8.2) of the voltage-gated potassium channel. Methods : The genetic testing of two patients included the next-generation sequencing of a retinal dystrophy panel and direct Sanger sequencing to confirm KCNV2 gene variants, in addition to an electroretinogram (ERG) and spectral domain optical coherence tomography (SD-OCT). Results : Cone dystrophy with supernormal rod response is associated with identified variants in the KCNV2 gene. The genetic analysis of the first case identified a compound heterozygous mutation in the KCNV2 gene, including a de novo nonsense duplication at cDNA position 1109, which led to the premature termination of the p.Lys371Ter codon in the second extracellular domain of the protein. Two patients showed changes in the full-field electroretinogram, especially in the first case, which demonstrated a close to supernormal total electroretinogram amplitude. This study increased the range of the KCNV2 mutation database, added an unreported de novo substitution pattern to KCNV2 gene variants, and linked it to the evaluated clinical studies. Conclusions : The initial clinical manifestations were varied, but both patients presented with hypermetropia and slight exotropia. The ERG findings are characteristic of KCNV2 mutations, and patients exhibited an increased b-wave latency in DA3.0 ERG (combined rod-cone response).
- Published
- 2024
- Full Text
- View/download PDF
37. [Outcomes of hemi-Descemet membrane endothelial keratoplasty and phacoemulsification for the treatment of primary Fuchs' endothelial corneal dystrophy combined with cataract].
- Author
-
Malyugin BE, Geliastanov AM, Antonova OP, Andreeva EA, Poletaeva MV, and Isabekov RS
- Subjects
- Humans, Descemet Membrane surgery, Endothelial Cells, Cornea, Phacoemulsification, Cataract complications, Cataract diagnosis, Corneal Transplantation, Fuchs' Endothelial Dystrophy complications, Fuchs' Endothelial Dystrophy diagnosis, Fuchs' Endothelial Dystrophy surgery
- Abstract
Purpose: This study evaluates the long-term results of surgical treatment of patients with Fuchs' endothelial corneal dystrophy and cataract., Material and Methods: The study included 24 patients (24 eyes) with primary Fuchs' endothelial corneal dystrophy and cataract, who underwent cataract phacoemulsification with IOL implantation and of Descemet's membrane endothelial keratoplasty with a semicircular graft (hemi-DMEK). The effect of treatment was assessed by best corrected visual acuity (BCVA), central corneal thickness (CCT) and endothelial cell density (ECD)., Results: In total, surgical treatment involved 14 donor corneas that were divided in half during the preparation and isolation of the Descemet's membrane (DM). By month 12 after the surgery an increase in visual functions and graft transparency were observed in 23 patients (23 eyes) out of 24. Repeated keratoplasty was required in one case due to fibrosis of the posterior layers of recipient's corneal stroma. At 12 months postoperatively, the study group showed an increase in BCVA from 0.16±0.1 to 0.75±20, a decrease in CCT from 650.9±4.5 μm to 519.6±43.9, and a decreased in ECD from 2850.5±84.7 cells/mm
2 up to 1285.5±277.2 cells/mm2 . Thus, the loss of endothelial cells at one year after surgery amounted to 54.9%., Conclusions: The developed method for transplantation of a semicircular DM fragment provides a tissue-saving approach to endothelial keratoplasty, and considering the high percentage of transparent engraftment of grafts and complete visual rehabilitation, it can be recommended in the treatment of patients with cataract and Fuchs' endothelial corneal dystrophy.- Published
- 2024
- Full Text
- View/download PDF
38. Different Methods of Secondary Intraocular Lens Implantation.
- Author
-
Forlini M, Malyugin B, Ahmed I, Scharioth G, Mastropasqua R, and Mularoni A
- Published
- 2023
- Full Text
- View/download PDF
39. Diagnostic Algorithm for Surgical Management of Limbal Stem Cell Deficiency.
- Author
-
Malyugin B, Kalinnikova S, Isabekov R, Ostrovskiy D, Knyazer B, and Gerasimov M
- Abstract
Background: Limbal stem cell deficiency (LCSD) presents several challenges. Currently, there is no clearly defined systematic approach to LSCD diagnosis that may guide surgical tactics., Methods: The medical records of 34 patients with LSCD were analyzed. Diagnostic modalities included standard (visometry, tonometry, visual field testing, slit-lamp biomicroscopy with corneal fluorescein staining, Schirmer test 1, ultrasonography) and advanced ophthalmic examination methods such as anterior segment optical coherence tomography, in vivo confocal microscopy, impression cytology, and enzyme-linked immunoassay., Results: Standard ophthalmological examination was sufficient to establish the diagnosis of LSCD in 20 (58.8%) cases, whereas advanced evaluation was needed in 14 (41.2%) cases. Depending on the results, patients with unilateral LSCD were scheduled to undergo glueless simple limbal epithelial transplantation (G-SLET) or simultaneous G-SLET and lamellar keratoplasty. Patients with bilateral LSCD with normal or increased corneal thickness were enrolled in the paralimbal oral mucosa epithelium transplantation (pLOMET) clinical trial., Conclusions: Based on the diagnostic and surgical data analyzed, the key points in LSCD diagnosis were identified, helping to guide the surgeon in selecting the appropriate surgical procedure. Finally, we proposed a novel step-by-step diagnostic algorithm and original surgical guidelines for the treatment of patients with LSCD.
- Published
- 2023
- Full Text
- View/download PDF
40. [Methods of diagnosis and treatment of corneal neovascularization].
- Author
-
Malyugin BE, Isabekov RS, Kalinnikova SY, and Antonova OP
- Subjects
- Humans, Cornea, Corneal Neovascularization diagnosis, Corneal Neovascularization etiology, Corneal Neovascularization therapy, Corneal Diseases
- Abstract
Corneal neovascularization is one of the most common causes of decreased visual acuity and disability for vision loss, increase in the risk of corneal graft rejection, and appearance of opacifications on the cornea. This article reviews literature on etiological factors of the development of corneal neovascularization, as well as modern methods of diagnosis, conservative and surgical treatment of this pathology.
- Published
- 2023
- Full Text
- View/download PDF
41. [Long-term outcomes of treating rhegmatogenous retinal detachment with macular hole using platelet-rich blood plasma].
- Author
-
Malyugin BE, Shkvorchenko DO, and Khurdaeva AG
- Subjects
- Female, Humans, Male, Prospective Studies, Retrospective Studies, Tomography, Optical Coherence, Visual Acuity, Vitrectomy methods, Platelet-Rich Plasma, Retinal Detachment diagnosis, Retinal Detachment etiology, Retinal Detachment surgery, Retinal Perforations diagnosis, Retinal Perforations etiology, Retinal Perforations surgery
- Abstract
Currently there is no specific algorithm for treating rhegmatogenous retinal detachment complicated by macular hole., Purpose: The study analyzed the long-term outcomes of surgical treatment of rhegmatogenous retinal detachment (RRD) complicated by macular hole (MH) using platelet-rich plasma (PRP) and local staining of the internal limiting membrane (ILM)., Material and Methods: This prospective open-label study included 27 patients (15 females and 12 males) aged 57 to 65 (59.2±7.2) years. In all studied cases, RRD complicated by MH was determined. The best corrected visual acuity (BCVA) before surgery was 0.05±0.01 (from 0.02 to 0.08). The average MH diameter measured with OCT was 576.3±150.4 μm (409 μm to 944 μm). After vitrectomy, a perfluororganic compound (PFOC) was injected into the MH area in amount of 2-3 optic nerve head diameters to prevent the ingress of dye under the retina, then the internal limiting membrane (ILM) was stained and removed. After sequential PFOC/air replacement, PRP was injected into the macular hole site., Results and Discussion: An increase in BCVA from 0.05±0.01 to 0.09±0.03 was observed in the preoperative period one month after surgery, with a further increase to 0.35±0.11 at the maximum follow-up time (two years). The MH was blocked and a glial scar was present in all cases according to OCT data. 1-2 years after the operation, all patients showed a favorable anatomical effect according to OCT data. According to computer microperimetry data, mean macular photosensitivity was 23.8±1.3 dB two years after the surgery., Conclusions: This study shows a favorable anatomical and functional effect in patients with RRD and MH within a 2-year follow-up. A comparative study involving a larger cohort of patients is required to clarify the indications and contraindications for the use of the studied technique.
- Published
- 2023
- Full Text
- View/download PDF
42. [Analysis of the results of modified personalized topographically and tomographically oriented technique of ultraviolet corneal collagen crosslinking].
- Author
-
Solodkova EG, Malyugin BE, Fokin VP, Balalin SV, Lobanov EV, Zakharov IN, and Le VH
- Subjects
- Humans, Photosensitizing Agents, Visual Acuity, Corneal Topography, Riboflavin, Ultraviolet Rays, Cross-Linking Reagents therapeutic use, Collagen, Keratoconus diagnosis, Keratoconus drug therapy, Photochemotherapy methods
- Abstract
Purpose: The study aims to develop a modified personalized topographically and tomographically oriented technique of ultraviolet corneal collagen cross-linking (UVCXL) to affect the area of the cornea with weakest biomechanical properties as determined by mathematical modeling., Material and Methods: Modeling of the biomechanics of keratoconic cornea under conditions of external diagnostic action was done using COMSOL Multiphysics
® software. Finite-element analysis procured 3D images of stress/deformation distribution pattern throughout the cornea. Matching these 3D images with primary topographic and tomographic Pentacam AXL maps and Corvis ST findings allowed determining localization and dimensions of impaired regions of the cornea. The acquired data helped develop the modified corneal collagen cross-linking technique, which was applied in the treatment of 36 persons (36 eyes) with degrees I and II keratoconus., Results: Uncorrected and best-corrected visual acuity (UCVA and BCVA logMAR) in all patients after modified UVCXL increased after the follow-up period lasting 6-12 months by 0.2±0.19 (23%) and 0.1±0.14 (29%) ( p <0.05), respectively, in comparison with preoperative values. Maximum keratometry (Kmax ) decreased by 1.35±1.63% (3%; p <0.05) in all cases at 6-12 months follow-up. Improvement of corneal biomechanical strength was determined by statistically significant increase in corneal stiffness index (SP-A1) and corneal stress-strain index (SSI) measured with Pentacam AXL and Corvis ST at 6-12 months follow-up by 15.1±5.04 (18%) and 0.21±0.20 (23%) ( p <0.05), respectively. Effectiveness of the developed UVCXL technique is also confirmed by the appearance of a characteristic morphological marker - «demarcation line» at the cross-linking site in keratoconus projection at the depth of 240±10.2 µm., Conclusion: The developed personalized topographically and tomographically oriented UVCXL technique provides an evident stabilizing effect on the cornea in the form of an increase in its biomechanical strength, improvement of clinical, functional indicators and safety of keratoconus treatment.- Published
- 2023
- Full Text
- View/download PDF
43. Removing residual cortical material during cataract surgery: Visco polishing and the grindstone effect as a new surgical technique.
- Author
-
Borkenstein AF, Borkenstein EM, and Malyugin B
- Subjects
- Humans, Lens Implantation, Intraocular methods, Capsule Opacification, Cataract, Cataract Extraction, Lens Capsule, Crystalline, Lens, Crystalline, Phacoemulsification methods
- Abstract
Purpose: To describe a new technique for removing residual cortical material adjacent to posterior lens capsule during cataract surgery with the help of cohesive ophthalmic viscosurgical devices., Methods: In this technique, if there are still cortical remnants and lens epithelial cells left after the routine irrigation-aspiration and polishing at the final steps of cataract surgery, the capsule is filled to about one-third with a highly viscous cohesive ophthalmic viscosurgical device. Rinsing is performed from the anterior chamber with the water jet directed tangentially to the ophthalmic viscosurgical device bolus and towards the posterior capsule, which creates a turbulence creating a "grindstone effect". The ophthalmic viscosurgical device bolus transforms into a ball and starts to rotate very quickly within the capsule, grinding away the cortical remnants., Results: In the first series of 62 cases, there were no intra-operative or post-operative complications. At day 1 there was no corneal oedema and no hypertension of intraocular pressure. Visual outcomes were good with a mean best corrected distance visual acuity of -0.01 ± 0.11 logMAR., Conclusion: This technique appears to be effective and fast in removing persistent cortical remnants from the surface of the posterior capsule, while minimising risks such as capsule aspiration during irrigation/aspiration. There is limited pressure and mechanical force applied on the capsule; the anterior chamber and the corneal endothelium remain safe since the ophthalmic viscosurgical device stays inside the capsular bag to its high cohesiveness and molecular weight. More data on a larger cohort of patients is planned to confirm these results and evaluate long-term effects on posterior capsule opacification.
- Published
- 2022
- Full Text
- View/download PDF
44. Corectopia grading: A novel classification system.
- Author
-
Anisimova N, Arbisser L, Tzamalis A, Petrovski BÉ, Shilova N, Petrovski G, Anisimov S, and Malyugin B
- Subjects
- Humans, Observer Variation, Pupil, Reproducibility of Results, Pupil Disorders
- Abstract
Objectives: To present and validate the novel grading system for objective classification of corectopia., Subjects and Methods: We evaluated 28 eyes of 28 patients with or without corectopia and validated the grading and classification system for corectopia according to three major criteria: (i) direction, (ii) extent, and (iii) alteration of mydriasis. Intraclass correlation coefficient (ICC) and inter-rater agreement between 7 inexperienced and 1 experienced ophthalmologist against a golden standard (GS) were calculated., Results: The ICC for the 7 inexperienced ophthalmologists regarding the grading of direction and centration of the pupil was 0.83 (95% confidence interval (CI), 0.74 to 0.90; p < .001) and 0.57 (95% CI, 0.43 to 0.72; p < .001), respectively. The inter-rater agreement was the same or almost the same in cases of pupil decentration between the inexperienced, experienced ophthalmologists and the GS (k = 0.82; 95% CI, 0.64-1.00; p < .001). In assessing the direction of pupil displacement, the inter-rater agreement was almost perfect between the inexperienced (k = 0.93; 95% CI, 0.84-1.00; p < .001) and experienced (k = 0.92; 95% CI: 0.82-1.02; p < .001) ophthalmologists and the GS., Conclusion: The first detailed clinical classification is proposed for objective corectopia grading particularly relevant in documenting and assessing progressive disease. It was confirmed to be acceptable for clinical use by inexperienced and experienced ophthalmologists alike.
- Published
- 2022
- Full Text
- View/download PDF
45. [Outcomes of surgical treatment of rhegmatogenous retinal detachment after phaco surgery and implantation of a trifocal intraocular lens in patients with myopia (clinical observations)].
- Author
-
Malyugin BE, Sobolev NP, Shkvorchenko DO, Fomina OV, Lanevskaya NI, and Obraztsova MR
- Subjects
- Humans, Lens Implantation, Intraocular adverse effects, Patient Satisfaction, Prosthesis Design, Refraction, Ocular, Lenses, Intraocular, Myopia complications, Myopia diagnosis, Myopia surgery, Phacoemulsification adverse effects, Retinal Detachment diagnosis, Retinal Detachment etiology, Retinal Detachment surgery
- Abstract
Purpose: To analyze visual functions in moderate and high myopic patients with retinal detachment that developed after implantation of a trifocal intraocular lens (IOL)., Material and Methods: The study analyzed the functional outcomes achieved in 3 patients (4 eyes) with retinal detachment developed after implantation of AcrySof IQ PanOptix («Alcon», USA) and AT LISA tri 839 MP («Carl Zeiss Meditec», Germany) during the follow-up period of 24 months. Patient examination included measurements of visual acuity at far (4 and 5 m), near (40 cm) and intermediate distances (60 cm, 80 cm), spatial contrast sensitivity, spherical equivalent of refraction, and a survey of patients for subjective satisfaction of the obtained vision., Results: In four eyes of three patients with moderate and high myopia, rhegmatogenous retinal detachment was diagnosed during the follow-up period at 4 to 12 months after phacoemulsification of cataract with trifocal IOL implantation. The best visual indicators were found in patient N . as a result of surgical treatment of bilateral rhegmatogenous retinal detachment due to high myopia: visual acuity (VA) at far distance was 1.0 for each eye (with 100 points on the VF-14 questionnaire). In patients P . and M ., after the development of unilateral rhegmatogenous retinal detachment, complete retinal reattachment was achieved after surgery with VA at far distance 0.55 (OS) in patient P . and 0.4 (OD) in patient M . (95 and 86 points on VF-14, respectively)., Conclusion: Good visual functions were achieved in three patients with trifocal IOL after surgical treatment of the rhegmatogenous retinal detachment that developed due to myopia. The implanted trifocal IOL did not affect the effectiveness of vitrectomy. After the treatment patients retained the ability to see at different distances.
- Published
- 2022
- Full Text
- View/download PDF
46. [Pharmacological modulation of wound healing in glaucoma surgery].
- Author
-
Malyugin BE, Sidorova AV, Starostina AV, Zhuravlev AS, Khaletskaya AA, Eliseeva MA, and Smirnova EA
- Subjects
- Humans, Mitomycin, Wound Healing, Filtering Surgery adverse effects, Glaucoma drug therapy, Glaucoma surgery, Trabeculectomy
- Abstract
Despite the well-known effectiveness of pharmacological glaucoma therapy, surgical approach remains one of the main treatment options for some forms and stages of the disease. The long-term success of glaucoma surgery depends on the intensity of local wound healing processes at the surgical site. The most common way to influence healing processes in surgical treatment of glaucoma is the use of antimetabolites. However, given the high risk of serious complications associated with their use, the search for new drugs devoid of these disadvantages continues. The aim of this review is to describe the efficacy and safety of both currently used and upcoming pharmacological ways to influence the wound healing process after glaucoma surgery in order to improve the stability of hypotensive effect.
- Published
- 2022
- Full Text
- View/download PDF
47. Ophthalmic Viscosurgical Devices (OVDs) in Challenging Cases: a Review.
- Author
-
Borkenstein AF, Borkenstein EM, and Malyugin B
- Abstract
Ophthalmic viscoelastic devices (OVDs) are currently used in cataract surgery and have significantly improved the safety and effectiveness of this surgical procedure. OVDs are classified according to the zero-shear viscosity and the cohesion-dispersion index in cohesive, dispersive, and viscoadaptives. OVDs create and maintain anterior chamber depth and visibility, protecting the corneal endothelium and other intraocular tissues during surgery. The selection of the most adequate OVD is especially relevant when performing cataract surgery in challenging cases, such as in hard, mature cataracts, flat anterior chamber, pseudoexfoliation syndrome, intraoperative floppy iris syndrome, or glaucoma surgery. In such cases, OVD is crucial for facilitating the surgical procedure and the associated minimal complication rate. The use of a combination of OVDs (soft-shell technique and modifications), the use of blue-colored OVDs, and the combination of sodium hyaluronate with lidocaine have also been described as useful tools in some of these challenging cases., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
48. Keratoconus Diagnostic and Treatment Algorithms Based on Machine-Learning Methods.
- Author
-
Malyugin B, Sakhnov S, Izmailova S, Boiko E, Pozdeyeva N, Axenova L, Axenov K, Titov A, Terentyeva A, Zakaraiia T, and Myasnikova V
- Abstract
The accurate diagnosis of keratoconus, especially in its early stages of development, allows one to utilise timely and proper treatment strategies for slowing the progression of the disease and provide visual rehabilitation. Various keratometry indices and classifications for quantifying the severity of keratoconus have been developed. Today, many of them involve the use of the latest methods of computer processing and data analysis. The main purpose of this work was to develop a machine-learning-based algorithm to precisely determine the stage of keratoconus, allowing optimal management of patients with this disease. A multicentre retrospective study was carried out to obtain a database of patients with keratoconus and to use machine-learning techniques such as principal component analysis and clustering. The created program allows for us to distinguish between a normal state; preclinical keratoconus; and stages 1, 2, 3 and 4 of the disease, with an accuracy in terms of the AUC of 0.95 to 1.00 based on keratotopographer readings, relative to the adapted Amsler-Krumeich algorithm. The predicted stage and additional diagnostic criteria were then used to create a standardised keratoconus management algorithm. We also developed a web-based interface for the algorithm, providing us the opportunity to use the software in a clinical environment.
- Published
- 2021
- Full Text
- View/download PDF
49. Cataract Surgery in Very Old Patients: A Case-Control Study.
- Author
-
Nussinovitch H, Tsumi E, Tuuminen R, Malyugin B, Lior Y, Naidorf Rosenblatt H, Boyko M, Achiron A, and Knyazer B
- Abstract
Advancements in surgical techniques and increased life expectancy have made cataract surgery more common among very old patients. However, surgical outcomes seem impaired in patients older than 90 years, especially with ocular comorbidities. A retrospective case-control study of 53 eyes of 53 very old patients (mean 92.6 ± 3.0) and 140 eyes of 140 matched patients (mean 75.2 ± 7.6) was undertaken. Groups were matched in terms of gender and systemic and ocular comorbidities. In very old patients, higher phacoemulsification energy (cumulative dissipated energy [CDE], 25.0 ± 22.4 vs. 16.1 ± 10.7, p = 0.01) and rate of intraoperative floppy iris syndrome (IFIS, 9.4% vs. 1.4%, p = 0.02) were observed compared to controls. Uncorrected (UCVA) and best-corrected distance visual acuity (BCVA) gains were significantly poorer among the very old patients than among the control at postoperative day 30 (0.20 ± 0.70 vs. 0.56 ± 0.61 logMAR, p < 0.001 and 0.27 ± 0.64 vs. 0.55 ± 0.62 logMAR, p = 0.006, respectively). Even after including CDE and IFIS as covariates, age remained an independent factor for poor visual gain at 30 days ( p < 0.001). Cataract surgery in very old patients may demand more experienced surgeons due to higher nuclear density and the rates of IFIS. Expectations in visual acuity gains should be aligned with the patient's age.
- Published
- 2021
- Full Text
- View/download PDF
50. [Effects of artificial gravity on perimetry results].
- Author
-
Malyugin BE, Koloteva MI, Pozdeyeva NA, Morozova TA, Sychova DV, Pikusova SM, and Mashkov DA
- Subjects
- Adult, Eye, Humans, Male, Sensitivity and Specificity, Visual Fields, Gravity, Altered, Visual Field Tests
- Abstract
The active exploration of space requires minimizing negative effects induced by weightlessness (microgravity). Risk reduction can be achieved with the use of artificial gravity created by short-radius centrifuge (SRC). Short-radius centrifuge causes redistribution of body liquids towards the caudal portion of the body imitating a vertical human pose. Presently, studying the safety of this prevention method for the human body in general, and for the visual system in particular, is one of the priority tasks of space medicine., Purpose: To study the effects of artificial gravity on the perimetry measurements of the eye., Material and Methods: The study included 9 volunteers (men) aged 31.2±6 years (from 25 to 40 years). Each man was subjected to three rotations on SRC. The operative factor in the tests was overloads in the «head-pelvis» direction. Rotations were carried out in three different modes with varying maximum overload value at the feet level of up to 2.0; 2.4; 2.9 G. Pulsar-perimetry was carried out before and 1-2 hours after the rotations estimating the mean threshold of retinal photosensitivity Mean Sensitivity (MS), mean loss of sensitivity Mean Defect (MD), square root of Loss Variance (sLV); the Bebie curve; additionally, cluster analysis was performed., Results: Mean threshold of retinal photosensitivity, mean loss of photosensitivity, square root of Loss Variance by Pulsar-perimetry before (MS=22.75 dB; MD= -0.6 dB; sLV=1.5) and after rotations on SRC (in Mode 1: 23.4; -0.2; 1.5, Mode 2: 23.2; -0.4; 1.4 and Mode 3: 23.5; -0.8; 1.4 respectively) did not change significantly. No adverse phenomena were detected in the eyes., Conclusions: There were no significant changes in the visual fields of the test subjects after rotations in three different modes according to Pulsar-perimetry data, which gives reason to tentatively conclude that using SCR in these modes is safe for the visual sensory system. According to preliminary data, this method can be successfully used to reduce the risk of long-term space flights and prevent unwanted phenomena caused by weightlessness.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.